145 related articles for article (PubMed ID: 35926814)
1. Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.
Lamarca A; Morfouace M; Tejpar S; Oliveira J; Capela A; Penel N; Gennigens C; Brasiuniene B; Peron J; Stevovic A; Blay JY; Klümpen HJ
Ann Oncol; 2022 Nov; 33(11):1200-1202. PubMed ID: 35926814
[No Abstract] [Full Text] [Related]
2. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.
Morfouace M; Stevovic A; Vinches M; Golfinopoulos V; Jin DX; Holmes O; Erlich R; Fayette J; Croce S; Ray-Coquard I; Girard N; Blay JY
ESMO Open; 2020 Dec; 5(6):e001075. PubMed ID: 33262201
[TBL] [Abstract][Full Text] [Related]
3. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.
de Rojas T; Kasper B; Van der Graaf W; Pfister SM; Bielle F; Ribalta T; Shenjere P; Preusser M; Fröhling S; Golfinopoulos V; Morfouace M; McCabe MG
Int J Cancer; 2020 Aug; 147(4):1180-1184. PubMed ID: 31465545
[TBL] [Abstract][Full Text] [Related]
4. EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
Tagliamento M; Morfouace M; Loizides C; Oliveira J; Greillier L; Raimbourg J; Toffart AC; Chatellier T; Cloarec N; Sullivan I; Brasiuniene B; Duruisseaux M; Oselin K; Robert MS; Fernandes C; Poncin A; Blay JY; Besse B; Girard N
NPJ Precis Oncol; 2024 Feb; 8(1):37. PubMed ID: 38366021
[TBL] [Abstract][Full Text] [Related]
5. Overview of personalized medicine in GI cancers.
Chao C
J Gastrointest Surg; 2012 Sep; 16(9):1641-4. PubMed ID: 22744640
[TBL] [Abstract][Full Text] [Related]
6. Ushering in the Era of Precision Medicine.
Oncology (Williston Park); 2020 Aug; 34(8):314-316. PubMed ID: 32785927
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Søreide K
Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277036
[No Abstract] [Full Text] [Related]
8. Precision Medicine in Gastrointestinal Pathology.
Wang DH; Park JY
Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiles in foregut oncology.
Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
[TBL] [Abstract][Full Text] [Related]
10. Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors.
Passardi A; Scarpi E; Ulivi P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762586
[TBL] [Abstract][Full Text] [Related]
11. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
12. Molecular targets in GI malignancies - A pathologist's perspective.
Pawar S; Sharma A
Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S43-S51. PubMed ID: 34135137
[TBL] [Abstract][Full Text] [Related]
13. Introduction: personalized medicine in gastrointestinal cancer.
Riall TS
J Gastrointest Surg; 2012 Sep; 16(9):1639-40. PubMed ID: 22752473
[No Abstract] [Full Text] [Related]
14. The current state of molecular profiling in gastrointestinal malignancies.
Mukherji R; Yin C; Hameed R; Alqahtani AZ; Kulasekaran M; He AR; Weinberg BA; Marshall JL; Hartley ML; Noel MS
Biol Direct; 2022 Jun; 17(1):15. PubMed ID: 35668531
[TBL] [Abstract][Full Text] [Related]
15. The current status and problems confronted in delivering precision medicine in Japan and Europe.
Bando H
Curr Probl Cancer; 2017; 41(3):166-175. PubMed ID: 28391973
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for personalized medicine in GI cancers.
Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
[TBL] [Abstract][Full Text] [Related]
17. SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumors.
Nakamura Y; Fujisawa T; Taniguchi H; Bando H; Okamoto W; Tsuchihara K; Yoshino T; Ohtsu A
Cancer Sci; 2021 Nov; 112(11):4425-4432. PubMed ID: 34510657
[TBL] [Abstract][Full Text] [Related]
18. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
[TBL] [Abstract][Full Text] [Related]
19. Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
Giordani E; Zoratto F; Strudel M; Papa A; Rossi L; Minozzi M; Caruso D; Zaccarelli E; Verrico M; Tomao S
Curr Cancer Drug Targets; 2016; 16(2):175-85. PubMed ID: 26278713
[TBL] [Abstract][Full Text] [Related]
20. 2014 Gastrointestinal Cancers Symposium.
McLarnon A
Lancet Oncol; 2014 Mar; 15(3):262. PubMed ID: 24809097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
